Tag: pcdna3.1 zeo

Imaging the Gut with "CLARITY"
Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.

Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.

Right here, we suggest a plasmonic enzyme-linked immunosorbent assay (ELISA) primarily based on extremely delicate colorimetric detection of alkaline phosphatase (ALP), which is achieved by iodine-mediated etching of gold nanorods

Curcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation

Curcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy ActivationCurcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation

Fibrosis contributes to graft loss in persistent renal allograft damage. Endothelial-to-mesenchymal transition (EndMT) performs an necessary position within the improvement of fibrosis following kidney transplantation. Autophagy performs an necessary position

A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia

A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemiaA recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia

Antibody fragments are promising constructing blocks for creating focused therapeutics, thus enhancing remedy efficacy whereas minimising off-target toxicity. Regardless of latest advances in focused therapeutics, sufferers with Philadelphia-like acute lymphoblastic leukemia